Vergoeding 2019-2023 voor ATC-subgroep N06AX : Overige antidepressiva
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| N06AX03 Mianserine | 41.612 | 25.833 | 24.397 | 18.054 | 1.909 |
| N06AX05 Trazodon | 561.220 | 601.140 | 641.210 | 661.900 | 680.000 |
| N06AX11 Mirtazapine (Remeron ®) | 1.528.200 | 1.559.900 | 1.700.400 | 1.710.400 | 1.615.100 |
| N06AX12 Bupropion (Wellbutrin ®) | 5.443.900 | 5.781.700 | 4.764.900 | 4.880.000 | 4.783.200 |
| N06AX16 Venlafaxine (Efexor ®) | 3.706.700 | 3.743.900 | 3.538.300 | 3.867.800 | 4.109.600 |
| N06AX21 Duloxetine (Cymbalta ®) | 1.755.000 | 1.815.600 | 1.682.900 | 1.766.600 | 1.833.400 |
| N06AX22 Agomelatine (Valdoxan ®) | 677.550 | 507.440 | 431.790 | 428.950 | 334.560 |
| N06AX26 Vortioxetine (Brintellix ®) | 1.376.300 | 1.546.300 | 1.585.200 | 1.689.000 | 1.810.000 |
| Totaal | 15.090.482 | 15.581.813 | 14.369.097 | 15.022.704 | 15.167.769 |